Organization
University of York
2 clinical trials
2 abstracts
Clinical trial
A Phase IIb Study to Assess the Safety, Efficacy and Immunogenicity of the Leishmania Vaccine ChAd63-KH in Post-kala Azar Dermal LeishmaniasisStatus: Completed, Estimated PCD: 2022-08-31
Clinical trial
A Multicentre Observational Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral LeishmaniasisStatus: Recruiting, Estimated PCD: 2024-11-01
Abstract
Increasing the study of novel anticancer therapies in adolescents: Facilitating adolescent inclusion in adult research.Org: Novartis Pharmaceuticals Corporation, Bristol-Myers Squibb, EV Pharma Solutions Ltd., AstraZeneca, Gustave Roussy Institute,
Abstract
A NEW APPROACH TO MAXIMISE THE VALUE OF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITISOrg: York Health Economics Consortium, University of York, Market Access and Reimbursement, Wyeth Europa, Strategic Planning,